from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv3001c/ilvC

LFCtreatmentdescriptionclass of inhibitor

0.745

Amikacinug/mL Amikacintranslation

-1.449

Cap5-10ug/mL Capreomycintranslation

-1.631

Rox10-50 ug/mL Roxithromycintranslation

1.488

SM2-5 ug/mL Streptomycintranslation

-1.531

Tet5-10 ug/mL Tetracyclinetranslation

0.587

Rif0.2-5ug/mL Rifampicintranscription

0.610

Rifp0.1-0.5ug/mL Rifapentinetranscription

-1.154

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

-0.127

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

-0.099

CPZ10-50 ug/mL Chlorpromazinerespiration

-1.109

Clofazimine10-13 ug/mL Clofaziminerespiration

0.024

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

0.274

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

-0.562

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

0.020

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

-0.550

Econazole10-24 ug/mL Econazole (azole drug)respiration

-0.585

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

-0.622

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

0.047

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

0.057

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

-0.097

KCN5-20 ug/mL Potassium cyaniderespiration

-0.106

NaN30.2-2 mM Sodium aziderespiration

0.408

Nigericin50 uM Nigericinrespiration

-0.347

TRC10-150 ug/mL Triclosanrespiration

-0.512

TRZ10-25 ug/mL Thioridazinerespiration

-0.394

Valinomycin0.5-10 uM Valinomycinrespiration

-0.755

ZnSO42 mM ZnSO4respiration

0.245

menadione6-10 ug/mL Menadionerespiration

0.305

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

-0.096

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

0.608

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

-0.335

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

-0.248

NRP_1Non-replicating persistence stage 1dosRassociated

0.395

Amp0.2mg/mL AmpicillincellWall

0.461

Cephalexin20-100 ug/mL CephalexincellWall

-0.038

Cerulenin0.32-5 ug/mL CerulenincellWall

0.341

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

0.188

EMB10-20 ug/mL EthambutolcellWall

0.276

Eta12-40 ug/mL EthionamidecellWall

0.552

INH0.2-0.4 ug/mL IsoniazidcellWall

0.944

TLM0.1-0.2 mg/mL ThiolactomycincellWall

-0.330

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.010

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-1.523

BZA0.12 mg/mL BenzamidearomaticAmides

-1.461

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

-1.040

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

0.673

H2O24 mM hydrogen peroxideDNAdamaging

0.360

Levo10 ug/mL LevofloxacinDNAdamaging

0.680

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

-0.510

Novobiocin10 ug/mL NovobiocinDNAdamaging

0.823

Oflox5-10 ug/mL OfloxacinDNAdamaging

0.810

UVUV-irradiationDNAdamaging

-0.507

ARP41-4 ug/mL Antitubercular compound ARP4?

0.480

Antimycin12.5-50 ug/mL Antimycin A?

-0.146

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

0.521

PA_110-50 ug/mL Antitubercular compound PA-1?

0.443

PA_2110-50 ug/mL Antitubercular compound PA-21?

0.150

PA8240.2-2 ug/mL PA-824?

0.340

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

0.676

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

-0.127

Verapamil50 uM Verapamil?

0.453

mercaptoethanol2 mM 2-Mercaptoethanol?

-0.146

methoxatin10-20 ug/mL Methoxatin?